Publishing Guide

Peer Review in 2026: What the Capacity Crisis Means for Authors Submitting Now

Submission volumes are outpacing reviewer availability, desk rejection rates have risen sharply, and the editing labor keeping journals running is concentrated in a shrinking fraction of the research community. Here is what every author needs to understand before hitting submit.

MZ
Dr. Meng Zhao|Physician-Scientist · Founder, LabCat AI
Published: September 202616 min readPublishing Guide

Peer Review Week 2026, which ran September 14 through 18, was organized around a theme that has been building for years: “Peer Review Capacity: Volume, Speed, and Quality.” The framing was deliberately pointed. Scholarly publishing has accumulated a structural mismatch between the number of manuscripts submitted and the number of qualified, willing reviewers available to evaluate them, and the gap has grown wide enough that it now affects almost every decision an author makes, from journal choice to submission timing to how long to wait before following up.

The problems are related but distinct. Volume is a numbers problem. Speed is an expectations problem. Quality is what suffers when the first two pull in opposite directions. Understanding how they interact helps authors respond more strategically rather than simply accepting delays as bad luck.

The Core Tension

The number of papers being submitted is growing roughly three times faster than the reviewer pool. The reviewers doing the most work are already stretched. Journals are absorbing that strain partly through faster desk rejection and partly by relying on a smaller and smaller group of committed individuals.

What the Numbers Actually Look Like

Submissions to major academic journals have risen approximately 68 percent between 2018 and 2025, and the early 2026 data suggests the acceleration has not slowed. Some journals reported submission increases as high as 34 percent comparing the first half of 2026 with the same period in 2025. The American Speech-Language-Hearing Association's journals, to take one well-documented example, saw submission numbers climb nearly 40 percent from 2020 to 2025, and by September 1, 2026, they had already received 2,000 manuscripts for the year with four months still to go.

That growth is driven by several converging factors. The global research workforce is larger than at any prior point. Open access mandates from funders in Europe, the United States, and increasingly in Asia-Pacific have created strong incentives to publish. The expansion of AI-assisted writing tools has lowered the friction of completing a first draft. And the pressure to publish remains as structurally embedded in academic careers as ever. None of these factors are going away. The submission curve is not a blip.

On the reviewer side, the picture is strikingly uneven. Research published in recent years on reviewer distribution has consistently found that roughly 20 percent of researchers account for somewhere between 69 and 94 percent of all peer review labor. That concentration matters because the high performers in that 20 percent are already receiving more review invitations than they can accept, and the invitations keep coming. There is no natural mechanism that will expand the reviewer pool fast enough to match submission growth. The journals that managed well in 2019 are running on the same review infrastructure in 2026, but with far more manuscripts arriving at the gate.

Desk Rejection Is the First Response, and It Has Gotten More Common

Editors dealing with volume overload have one lever that does not require reviewer involvement: rejecting manuscripts before external review begins. In 2025, journals across disciplines were desk-rejecting approximately 2.5 manuscripts for every one they accepted, up from roughly 1.7 per acceptance in 2022. That is a substantial shift in a short window, and it reflects editorial behavior more than any formal policy change.

What editors are triaging at the desk varies by journal but tends to cluster around a few predictable categories. Scope mismatches come first. If a manuscript is plausibly outside what the journal covers, and the fit requires serious imaginative effort, it goes back. Methodological red flags come next: underpowered study designs, reporting that clearly deviates from the relevant guidelines (CONSORT, STROBE, PRISMA, or others), missing trial registration numbers. Papers that are clearly duplicated elsewhere or that share characteristics with known predatory or paper mill submissions are also returned quickly.

What editors are checking before sending a paper to review

  • 1.Scope fit: does this paper belong in this journal, specifically?
  • 2.Reporting compliance: does the methods section follow the relevant reporting guideline?
  • 3.Registration: for clinical trials and systematic reviews, is registration cited and dated correctly?
  • 4.Ethics statement: is IRB or ethics board approval documented in the manuscript?
  • 5.Novelty signal: does the abstract give the editor a reason to spend reviewer attention on this paper?

The practical implication for authors is that the editorial office now spends measurably less time deliberating over borderline desk-rejection decisions than it did three years ago. Volume pressure tilts close calls toward rejection, because the cost of sending a questionable paper to review is borne by the reviewer, not the journal. Authors who once might have hoped that a sympathetic editor would read past an imperfect abstract or overlook an unstated registration number are now more likely to receive a return-without-review decision in under a week.

What Reviewer Overload Does to the Review Itself

Papers that pass desk screening go into a queue for external review. There the capacity crunch shows up differently. Editors find it harder to recruit reviewers for any given manuscript because the most suitable experts are already over-committed. First invitations are declined more often. Second and third choices get invited, which can mean someone with adjacent expertise rather than direct expertise. The review itself, when it arrives, may reflect the reviewer's time constraints as much as their judgment: shorter, less detailed, more focused on obvious methodological issues than on nuanced interpretation.

None of this is a criticism of reviewers. The Peer Review Week 2026 panel discussions explicitly named “invisible labor” as a real problem. Review is not rewarded in most academic institutions. It does not appear on grants, does not count in most promotion dossiers, and does not generate authorship credit. The researchers who do the most of it are doing so partly out of professional obligation and partly out of community commitment, and those motivations have limits.

For authors, the downstream consequence is inconsistency. Two manuscripts of equivalent quality, submitted to the same journal in the same month, may receive substantively different reviews depending on which reviewer set was available and willing. This is not new, but the capacity crunch has amplified it. Review quality can now vary considerably not just across journals but across submission windows at the same journal.

What Journals Are Doing in Response

The responses vary by publisher and by journal culture. Some are straightforward process changes. Journals have tightened word count and supplementary file limits to reduce the reading burden on reviewers. Some have shifted from three reviewers to two as a default for initial review rounds, accepting somewhat higher variance in exchange for faster turnaround and fewer invitation failures. Journal transfer systems, sometimes called cascade submission or manuscript transfer networks, have become more widely used, allowing papers declined at one journal to move to another under the same publisher with prior reviews intact. For authors, this can compress the total time from first submission to decision if the receiving journal uses the transferred reviews rather than starting over.

Portable peer review, in which a review completed at one journal travels with the manuscript if the author submits elsewhere, has attracted renewed attention. The model has been around for years in different forms, most visibly through the Review Commons platform in life sciences, but uptake among high-impact medical journals has been slow. The argument in its favor is straightforward: completed reviews are a public good that should not be wasted when a manuscript moves. The argument against, from journal editors, is that reviews solicited for one scope and standard are not always appropriate for another.

Registered Reports as a Partial Solution

Some journals have expanded their Registered Reports pathway specifically because it redistributes reviewer effort. When an in-principle acceptance is granted before data collection, reviewers focus on methodology at the stage when feedback is most useful, and the final manuscript review is lighter. For researchers working in fields where these journals have Registered Reports options, this pathway can substantially reduce post-completion review time.

The AI in Peer Review Question

No Peer Review Week 2026 discussion avoided the question of whether artificial intelligence could help absorb some of the volume. The honest answer is: yes, for specific narrow tasks, with real limits on what should stay human.

On the editorial screening side, AI tools are already being used at several publishers to check reporting completeness (flagging, for example, whether a randomized trial's methods section mentions allocation concealment), to verify that cited references actually exist and are correctly attributed, and to scan for statistical reporting patterns that might warrant closer attention. These are tasks where automation reduces reviewer burden without replacing judgment. The concern about AI creeping beyond administrative screening into substantive review is legitimate. Research published in 2026 found that large-language-model-generated peer reviews were already circulating in the system at scale, and their presence is harder to detect than many editors initially assumed.

Where human review remains irreplaceable is in evaluating whether a study's conclusions are supported by its design, whether the interpretation accounts for important confounds, and whether the findings matter to the field in a way that goes beyond meeting minimum methodological criteria. Those judgments require contextual knowledge that no current tool can adequately simulate. Peer Review Week 2026 participants who weighed in on this consistently drew the line at synthesis and evaluation: automation can handle administration, but the core scientific assessment must stay with people.

Authors have reason to care about where their target journals draw that line. A journal that uses AI heavily in prescreening may be faster but may also surface early-round rejections based on algorithmic pattern matching rather than editorial reading. A journal that relies exclusively on human reviewers with no administrative AI support may be slower but may produce more substantively engaged reviews when manuscripts do reach external evaluation. Neither approach is uniformly better; the fit depends on what the author needs.

What Authors Can Actually Do About This

The capacity crisis is structural and will not be resolved by individual authors behaving differently. But the authors who understand the pressure editors and reviewers are under can reduce unnecessary friction in their own submissions and improve their odds at journals that are managing the volume carefully.

The single highest-leverage step is writing a manuscript that makes a reviewer's job easier. This sounds trivial but is not. A reviewer who receives a paper with a clear, specific abstract, a methods section that follows the relevant reporting guideline, properly labeled tables and figures, and no unexplained abbreviations can focus on scientific evaluation. A reviewer who has to reverse-engineer the study design from a dense methods section, hunt for the ethics statement, and mentally reconstruct the sample size calculation will do all of that work in less time and with less patience than they would have done five years ago. The capacity crunch has shortened reviewer goodwill. Do not spend it on things a careful revision pass would have fixed.

Scope targeting matters more than it used to. With desk rejection rates climbing, submitting to a journal where the scope fit is genuinely clear rather than plausible-if-generous has become a more important part of the decision. This means reading several recent papers in the target journal, not just the author guidelines, and asking honestly whether this paper would sit comfortably alongside them. When the answer is uncertain, a pre-submission inquiry to the editorial office is not a sign of weakness. It is information-efficient, and many editorial offices respond quickly.

Practical checklist before submitting to a journal under capacity pressure

  • 01.Does the abstract state the question, methods, results, and conclusion in under 300 words without hedging or padding?
  • 02.Does the methods section cite and follow the appropriate reporting guideline by name (CONSORT, STROBE, PRISMA, ARRIVE, SPIRIT, TRIPOD)?
  • 03.Is trial or systematic review registration cited with a valid registration number and registration date that precedes enrollment?
  • 04.Does the cover letter explain, in two sentences, why this paper belongs in this journal specifically rather than its nearest competitor?
  • 05.Have you identified three to five suggested reviewers who have published on this exact question and have no obvious conflicts?
  • 06.Does the data availability statement match what is actually available, with any restrictions clearly explained?
  • 07.Have you checked whether the journal participates in a manuscript transfer network, in case the submission is declined?

Suggesting reviewers is worth doing seriously if the journal allows it. Editors struggling to recruit reviewers often act on author suggestions when the names are credible and the conflict-of-interest disclosures are clean. Three to five names of researchers who have published directly on the question, with institutional email addresses and no co-authorship or supervisory relationship with any of the submitting authors, is the format most likely to be used. Padding the list with tangential names to avoid engagement with the most critical experts in the field is a recognizable pattern and is not helpful.

Preprinting before submission is increasingly relevant in this context. Posting a preprint to medRxiv or bioRxiv before or concurrent with journal submission does not directly speed up peer review, but it allows the work to circulate and receive informal community feedback during the formal review period. Several journals actively monitor preprint servers and draw reviewer candidates from researchers who have already engaged with a preprint. In fields where preprinting is routine, this connection is becoming more systematic.

The Timing Question

Some authors ask whether there is a better or worse time of year to submit a manuscript given reviewer availability. The honest answer is that the data on this is mixed and journal-specific. Reviewers are often less available during August and December, and some editorial offices run at reduced capacity during major conference periods. Submitting just before these windows rather than just after has anecdotally shorter first-round turnaround times at some journals. But the effect is modest, journal-specific, and probably less important than the quality of the manuscript itself.

What is not anecdotal is that following up on a delayed decision makes sense at predictable intervals. Most journals publish their target decision times somewhere in their author instructions, and politely inquiring after 150 percent of that target time has elapsed is appropriate. Editors dealing with reviewer recruitment failures sometimes benefit from an author follow-up that prompts them to escalate to editorial board members or seek additional reviewers.

Where This Is Heading

The consensus from Peer Review Week 2026 was that the peer review model cannot be patched back to health through reviewer incentives alone. The volume of research being produced has exceeded the sustainable capacity of voluntary expert review at current expectations of speed and thoroughness. The field is moving, unevenly, toward a combination of approaches: tiered review with lighter-touch initial evaluation, expanded manuscript transfer to reduce duplicated effort, AI assistance for administrative tasks and reporting checks, and more structured pre-registration pathways that front-load reviewer effort at the design stage.

None of these changes are fully adopted by the journals most authors aspire to publish in. The high-impact general medical journals, including the New England Journal of Medicine, JAMA, The Lancet, and BMJ, operate on different economics and different editorial structures than specialty society journals, and they are not facing the same acute capacity pressure because their desk rejection rates are already high enough to limit the flow into external review. The capacity problem is most severe at journals that publish a broader range of work and feel obligated to send a higher proportion of submissions to external review.

For authors, the most durable response is writing papers that respect reviewer time from the opening sentence. The systems will adjust over the next few years. What will not change is that a well-prepared manuscript, submitted to a journal where it genuinely belongs, with complete reporting and a cover letter that makes the relevance explicit, will always navigate this environment better than one that relies on the system to work perfectly. Right now, the system is under considerable strain. That makes submission preparation more important, not less.

Further Reading

MZ

Written by Dr. Meng Zhao

Physician-Scientist · Founder, LabCat AI

MD · Former Neurosurgeon · Medical AI Researcher

Dr. Meng Zhao is a former neurosurgeon turned medical-AI researcher. After years in the operating room, he moved into applied AI for clinical workflows and now leads LabCat AI, a medical-AI company working on decision support and research tooling for clinicians. He built Journal Metrics as a free resource for researchers who need reliable journal metrics without paid database subscriptions.

Related Articles